Just as women can turn to a suite of procedures, known as the "Mommy Makeover," more men are embracing their own set of treatments, the "Daddy-Do-Over," to boost their confidence and improve their physical appearance. A new report from the American Society of Plastic Surgeons reveals that more than 1.3 million cosmetic procedures were performed on men last year alone, representing a 29 percent increase since 2000.
A new anatomic study highlights critical technical issues to ensure safe performance of the increasingly popular "Brazilian butt lift" – a procedure using the patient's own fat to augment and improve the appearance of the buttocks. The study appears in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Botulinum toxin injections like Botox® Cosmetic, Xeomin and Dysport, and the new Jeuveau remain supreme when it comes to facial rejuvenation solutions, according to the annual member survey from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). Botox injections are the most common non-surgical procedure year after year for both men and women with a 22 percent increase compared to 2013. This data reveals that facial tweaks and treatments continue to be embraced and are sought after at a marathon pace.
It’s one thing to have great skills as an aesthetic clinician, but practice management expertise is imperative to turning those skills into financial benefits. Understanding this critical need, The Aesthetic Show 2019, taking place July 11 – 14 at the Wynn Las Vegas, is making practice management a priority, offering a menu of course opportunities for attendees throughout the entire four-day event.
Every year for the past 15 years, the Vegas Cosmetic Surgery (VCS) meeting, taking place June 5 – 8, 2019, at the Bellagio in Las Vegas, Nev., brings together physicians from multiple disciplines with leading educators in the fields of facial plastic surgery, plastic surgery, dermatology and oculoplastic surgery.
Sponsored by Wontech
Cutaneous vascular disorders have been treated with a variety of medical methods, from sclerotherapy to energy-based devices like lasers and intense pulsed light (IPL), and even surgery. According to the extended theory of selective photothermolysis, long-pulsed lasers are preferred, with various wavelengths having been used to treat vascular lesions effectively and safely, including 577 nm, 585 nm, 595 nm, 532 nm, 755 nm, 1064 nm and others.
Sponsored by Viscot Medical
In the operative field, surgeons frequently need to mark patients before and sometimes during surgery on surfaces that are moist or covered with blood, fat and other fluids. The tips of most standard markers will usually stop writing on wet surfaces because they get clogged with fluids, which halts the flow of ink.
Sponsored Even with the proliferation of new technologies and treatments, the laser is still a frontline provider of outcomes. Among them, the SP Dynamis Pro™ dual-wavelength laser system from Fotona (based in the U.S. and Europe) remains a standout with two wavelengths (1064 nm Nd:YAG and 2940 nm Er:YAG) and unique modes of delivery. With these features, physicians can count on the platform to provide traditional therapies in difficult-to-treat areas, as well as novel applications such as hair regrowth.
Sponsored With a patient-friendly 585 nm wavelength and no consumables, the DenaVe diode laser by Quanta System (Milan, Italy) provides cost-effective treatment of vascular lesions and more.
Sponsored Picosecond lasers have been introduced as a breakthrough technology in the aesthetic and dermatologic fields, touting many reported advantages over other systems. However, many physicians still ask: “Is the picosecond laser really better than the nanosecond laser in real-world applications?” While not everyone may agree, I use a picosecond system called PICOCARE from Wontech, Ltd., Co. (Daejeon, South Korea), and, based on my experience with both a nanosecond laser and a picosecond laser, my answer to this question is “yes”.